Unraveling the role of ChREBP in lung adenocarcinoma: Expression, regulatory networks, and potential functional impact
6
item.page.dc.date.issued
2026-04-01
item.page.dc.type
item.page.dc.identifier.eissn
19326203
item.page.dc.identifier.doi
item.page.dc.identifier.scopus
2-s2.0-105037592098
item.page.oaire.citation.title
Plos One
item.page.oaire.citation.volume
21
item.page.oaire.citation.issue
4 April
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Plos One Vol.21 No.4 April (2026)
punsarn.item.page.citation
Ruangpracha A., Sae-Lee C., Chitta P., Grove H., Jamjuntra P., Amornrit W., Suriyaphol P., Thuwajit C., Poungvarin N. Unraveling the role of ChREBP in lung adenocarcinoma: Expression, regulatory networks, and potential functional impact. Plos One Vol.21 No.4 April (2026). doi:10.1371/journal.pone.0347907 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/116643
item.page.dc.title
Unraveling the role of ChREBP in lung adenocarcinoma: Expression, regulatory networks, and potential functional impact
item.page.dc.contributor.author
item.page.oairecerif.author.affiliation
item.page.dc.contributor.correspondence
item.page.dc.contributor.other
item.page.dc.description.abstract
Carbohydrate Response Element Binding Protein (ChREBP) is a transcription factor known to regulate glucose metabolism and other metabolic processes in various tissues, but its role in lung adenocarcinoma (LUAD) remains poorly understood. In this study, we investigated ChREBP expression and its role in regulating gene expression in LUAD cell lines. Using RT-qPCR, we assessed the expression of ChREBP-α and ChREBP-β isoforms in NCI-H1975, NCI-H1650, and NCI-H2228 LUAD cell lines. The NCI-H1975 cells exhibited the highest levels of both ChREBP isoforms, with a particularly pronounced expression of ChREBP-β. To explore the regulatory role of ChREBP, we generated NCI-H1975 cells with inducible expression of a dominant-negative mutant of human ChREBP (dnChREBP). Overexpression of dnChREBP led to a significant reduction in colony formation and impaired cell migration. Transcriptome analysis revealed 57 upregulated genes and 593 downregulated genes in dnChREBP-expressing cells compared to control cells. Functional annotation and gene set enrichment analysis revealed that the enriched genes were associated with cancer-related processes, including cell proliferation and epithelial-to-mesenchymal transition (EMT). Gene network analysis highlighted 17 downregulated hub genes, with 8 of these genes being associated with EMT. Interestingly, ChREBP and its transcriptionally regulated genes, including 4 top downregulated genes, 5 top upregulated genes, and 5 hub genes identified in NCI-H1975 cells overexpressing dnChREBP, showed significant prognostic value, as their expression levels correlated with overall survival in LUAD patients. Our findings suggest that ChREBP regulates distinct transcriptional programs in LUAD cells and ChREBP and its regulatory network may play a potential role in LUAD progression and patient outcomes.